CD274 and neoplasm: For instance, EV-miR-424-5p has been demonstrated to inhibit PD-L1 signaling, promote an inflammatory microenvironment in TNBC, increase the apoptosis of tumor cells in vitro, and restrain tumor progression in vivo.